Ignite Creation Date:
2025-12-24 @ 10:38 PM
Ignite Modification Date:
2026-05-27 @ 8:57 AM
Study NCT ID:
NCT01803035
Status:
COMPLETED
Last Update Posted:
2014-04-28
First Post:
2013-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo
Sponsor:
Lytix Biopharma AS
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-bullous Impetigo | View |